Idexx Laboratories (IDXX) Free Cash Flow (2009 - 2026)

Idexx Laboratories has reported Free Cash Flow for 18 years, with the latest figure at $322.5 million in Q2 2026.

• On a quarterly basis, Free Cash Flow rose 112.68% year-over-year to $322.5 million in Q2 2026; TTM through Jun 2026 was $1.3 billion, a 59.92% increase from a year earlier, with the FY2025 full-year figure at $1.1 billion, up 30.82% from the prior year.
• Free Cash Flow was $322.5 million for Q2 2026 at Idexx Laboratories, up from $234.3 million in the prior quarter.
• The five-year high for Free Cash Flow was $371.2 million in Q3 2025, with the low at $35.8 million in Q2 2022.
• Average Free Cash Flow over 5 years is $199.4 million, with a median of $200.0 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Free Cash Flow sank 83.08% in 2022, then jumped 383.29% in 2023.
• Over 5 years, Free Cash Flow stood at $124.2 million in 2022, then surged by 74.96% to $217.3 million in 2023, then advanced by 7.12% to $232.8 million in 2024, then surged by 40.19% to $326.3 million in 2025, then dropped by 1.17% to $322.5 million in 2026.
• The last three Free Cash Flow figures came in at $322.5 million (Q2 2026), $234.3 million (Q1 2026), and $326.3 million (Q4 2025), per Business Quant data.